Akèy › Myelom Miltip › Kalifòni › Baldwin Park
Etid klinik pou Myelom Miltip nan Baldwin Park, CA
23 etid pou Myelom Miltip ap chèche patisipan nan sit nan ak bò kote Baldwin Park (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Ap rekriteFaz 1
- City of Hope National Medical Center /ID# 280273, Duarte · 4 mi lwen
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
Ap rekriteFaz 1
- City of Hope, Duarte · 4 mi lwen
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
Ap rekriteFaz 1/2
- City of Hope National Medical Center, Duarte · 4 mi lwen
A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
Ap rekriteFaz 1
- Research Site, Duarte · 4 mi lwen
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Ap rekriteFaz 3
- City of Hope Duarte, Duarte · 4 mi lwen
Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
Ap rekriteFaz 2
- City of Hope Medical Center, Duarte · 4 mi lwen
A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma
Ap rekriteFaz 1/2
- City of Hope - Duarte, Duarte · 4 mi lwen
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Ap rekriteFaz 3
- City of Hope Duarte, Duarte · 4 mi lwen
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Ap rekriteFaz 4
- City of Hope, Duarte · 4 mi lwen
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
Ap rekriteFaz 3
- City of Hope National Medical Center, Duarte · 4 mi lwen
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Ap rekriteFaz 1
- City of Hope, Duarte · 4 mi lwen
A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
Ap rekriteFaz 1/2
- Research Site, Duarte · 4 mi lwen
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
Ap rekriteFaz 1/2
- Research Site, Duarte · 4 mi lwen
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
Ap rekriteFaz 1/2
- City of Hope, Duarte · 4 mi lwen
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Ap rekriteFaz 1/2
- City of Hope National Medical Center /ID# 273132, Duarte · 4 mi lwen
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
Ap rekriteFaz 1
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi lwen
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
Ap rekrite
- City of Hope, Duarte · 4 mi lwen
Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
Ap rekriteFaz 2
- City of Hope Medical Center, Duarte · 4 mi lwen
Mezigdomide (CC-92480) Post Idecabtagene Vicleucel in Treating Patients With Relapsed Multiple Myeloma
Ap rekriteFaz 1
- City of Hope Medical Center, Duarte · 4 mi lwen
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
Ap rekriteFaz 1
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi lwen
A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- City of Hope Medical Center, Duarte · 4 mi lwen
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- City of Hope, Duarte · 4 mi lwen
Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multiple Myeloma
Ap rekriteFaz 1
- City of Hope Medical Center, Duarte · 4 mi lwen
Etid Myelom Miltip nan lòt vil
- New York City, NY60 etid
- Boston, MA42 etid
- Atlanta, GA41 etid
- Houston, TX38 etid
- Durham, NC37 etid
- Nashville, TN32 etid
- Denver, CO27 etid
- Rochester, MN24 etid
- St. Louis, MO24 etid
- Columbus, OH24 etid
- Chicago, IL22 etid
- Seattle, WA22 etid
Lòt etid nan Baldwin Park
- Kansè nan tete45 etid
- Leksemi mieloïd egi40 etid
- Kansè kolorektal38 etid
- Kansè Poumon ki pa ti selil36 etid
- Kansè (tout kalite)33 etid
- Kansè pwostat30 etid
- Kansè Metastatik30 etid
- Sendwòm myelodisplastik26 etid
- Kansè ovè25 etid
- Kansè poumon24 etid
- Kansè lestomak22 etid
- Leksemi limfoblastik egi21 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.